Testing Services Revenue was CareDx’s largest product and service line in fiscal 2025, bringing in $274.50M of $379.81M (72%).
| Product and Service | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Testing Services Revenue | $263.75M | $209.69M | $249.38M | $274.50M | ||||||
| Service | — | — | — | — | ||||||
| Testing Services | — | — | — | — | ||||||
| Patient & Digital Solutions Revenue | — | $37.12M | $43.62M | $56.93M | ||||||
| Patient & Digital Solutions | $28.79M | — | — | — | ||||||
| Product Revenue | $29.25M | $33.52M | $40.78M | $48.38M | ||||||
| Product | — | — | — | — | ||||||
| Digital & Other | — | — | — | — | ||||||
| Digital & Other Revenue | — | — | — | — | ||||||
| License & Other | — | — | — | — | ||||||
| Royalty | — | — | — | — | ||||||
| Total | $321.79M | $280.32M | $333.79M | $379.81M |
CareDx brought in $379.81M from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 13.8% from $333.79M in fiscal 2024. Testing Services Revenue was the largest at $274.50M (72.3%), ahead of Patient & Digital Solutions Revenue at $56.93M (15.0%) and Product Revenue at $48.38M (12.7%).
Compared with fiscal 2024, Patient & Digital Solutions Revenue grew fastest, up 30.5% to $56.93M. Every line above 2% of revenue grew.
CareDx began breaking out Patient & Digital Solutions Revenue in fiscal 2023, when it brought in $37.12M. CareDx stopped reporting Patient & Digital Solutions as a separate line after fiscal 2022, when it brought in $28.79M.
United States was CareDx’s largest region in fiscal 2025, bringing in $359.94M of $379.81M (95%).
| Geography | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $307.54M | $265.63M | $317.73M | $359.94M | ||||||||
| North America | — | — | — | — | ||||||||
| Rest Of World | $4.70M | $14.69M | $16.05M | $19.87M | ||||||||
| Europe | $9.55M | — | — | — | ||||||||
| Total | $321.79M | $280.32M | $333.79M | $379.81M |
CareDx brought in $379.81M from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 13.8% from $333.79M in fiscal 2024. United States was the largest at $359.94M (94.8%), ahead of Rest Of World at $19.87M (5.2%).
Compared with fiscal 2024, Rest Of World grew 23.8% to $19.87M and United States grew 13.3% to $359.94M.
CareDx stopped reporting Europe as a separate region after fiscal 2022, when it brought in $9.55M.
CareDx (CDNA) reports its revenue by product and service and by geography. In fiscal 2025, Testing Services Revenue was its largest product and service line, bringing in $274.50M (72.3% of the total), followed by Patient & Digital Solutions Revenue at $56.93M (15.0%).
Testing Services Revenue was CareDx's largest product and service line in fiscal 2025, bringing in $274.50M, or 72.3% of the $379.81M total across its three product and service lines.
United States was CareDx's largest region in fiscal 2025, bringing in $359.94M, or 94.8% of the $379.81M total across its two regions.
Among CareDx's product and service lines that make up at least 2% of revenue, Patient & Digital Solutions Revenue grew fastest in fiscal 2025, up 30.5% from $43.62M to $56.93M.
Every figure comes from CareDx's annual financial filings, as reported. Each line keeps the name CareDx gives it, and years follow its fiscal calendar.
CareDx's revenue by product and service goes back to fiscal 2016, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.